Exclusive

Publication

Byline

Location

US Patent Issued to TORAY INDUSTRIES on Nov. 3 for "Allergen-immobilized carrier and method of detecting allergen-specific antibody" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,352, issued on Nov. 3, was assigned to TORAY INDUSTRIES Inc. (Tokyo). "Allergen-immobilized carrier and method of detecting allergen-specifi... Read More


US Patent Issued to DYNAMIC BIOSENSORS on Nov. 3 for "Cell immobilization in fluid at high flow velocities" (German, Danish Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,353, issued on Nov. 3, was assigned to DYNAMIC BIOSENSORS GMBH (Martinsried/Planegg, Germany). "Cell immobilization in fluid at high flow ve... Read More


US Patent Issued to The Regents of the University of California on Nov. 3 for "Cancer progression risk assessment by microvascular phenotype" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,354, issued on Nov. 3, was assigned to The Regents of the University of California (Oakland, Calif.). "Cancer progression risk assessment by... Read More


US Patent Issued to Ventana Medical Systems, Mayo Foundation for Medical Education and Research on Nov. 3 for "Methods and systems for evaluation of immune cell infiltrate in stage IV colorectal cancer" (Arizona, Minnesota Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,355, issued on Nov. 3, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.) and Mayo Foundation for Medical Education and Research (R... Read More


US Patent Issued to JAPANESE FOUNDATION FOR CANCER RESEARCH on Nov. 3 for "Sugar chain specific to prostate cancer, and test method using same" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,356, issued on Nov. 3, was assigned to JAPANESE FOUNDATION FOR CANCER RESEARCH (Tokyo). "Sugar chain specific to prostate cancer, and test m... Read More


US Patent Issued to AntlerA Therapeutics on Nov. 3 for "Antibodies that bind to LRP5 proteins and methods of use" (Canadian, American Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,357, issued on Nov. 3, was assigned to AntlerA Therapeutics Inc. (Toronto). "Antibodies that bind to LRP5 proteins and methods of use" was i... Read More


US Patent Issued to SEIKAGAKU on Nov. 3 for "Reagent for measuring B-glucan, method for producing same and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,358, issued on Nov. 3, was assigned to SEIKAGAKU Corp. (Tokyo). "Reagent for measuring B-glucan, method for producing same and use thereof" ... Read More


US Patent Issued to Novozymes BioAg on Nov. 3 for "Plasmid for bacillus expressing fluorescent reporter genes" (Virginia, North Carolina Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,359, issued on Nov. 3, was assigned to Novozymes BioAg A/S (Bagsvaerd, Denmark). "Plasmid for bacillus expressing fluorescent reporter genes... Read More


US Patent Issued to EUROIMMUN Medizinische Labordiagnostika on Nov. 3 for "Method and reagents for enhancing the chemiluminescent signal" (German Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,360, issued on Nov. 3, was assigned to EUROIMMUN Medizinische Labordiagnostika AG (Luebeck, Germany). "Method and reagents for enhancing the... Read More


US Patent Issued to Mayo Foundation for Medical Education and Research on Nov. 3 for "Identification and monitoring of acid hydrolysis products of immunoglobulin heavy chains" (Minnesota Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,361, issued on Nov. 3, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.). "Identification and monitoring... Read More